BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1424@pharmaconomics
DTSTAMP:20260707T003824Z
DTSTART;VALUE=DATE:20260723
DTEND;VALUE=DATE:20260724
SUMMARY:SNY PDUFA — Sarclisa
DESCRIPTION:The FDA's approval decision on Sarclisa for multiple myeloma is due Jul 23\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1121404/000119312526180848/d137048dex992.htm\n\nTrack it: https://pharmaconomics.com/e/1424
URL:https://pharmaconomics.com/e/1424
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:SNY catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR